Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,412.00    -18.00 (-0.41%)
Bid:
4,410.00
Ask:
4,416.00
Spread: 6.00 (0.136%)
Market Cap: £2.06b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Interim Management Statement

7 Nov 2013 07:00

RNS Number : 3954S
Morgan Sindall Group PLC
07 November 2013
 



 

 

7 November 2013

Morgan Sindall Group plc

 

Q3 Interim Management Statement

 

Morgan Sindall Group plc ('the Group') today announces its Interim Management Statement for the period from 1 July 2013 to date.

 

Group Performance

 

The overall Group performance in the third quarter ('Q3') was in line with the Board's expectations as at the time of the half year results on 5 August 2013 and followed a broadly similar trend to the first half. Within this, Group revenue held up well when compared to Q3 2012, whilst Group margin was impacted primarily by margin contraction in the Construction & Infrastructure division.

 

The Group's forward order book as at the end of Q3 was £3.3bn, up 6% from the half year position.

 

Operating Performance

 

In Construction & Infrastructure, there has been no significant change in market conditions or performance in Q3. The focus for the division remains on operational delivery, contract selectivity through the risk management of contractual terms & conditions and working capital management. As markets recover, upward pressure on material costs and subcontractor costs will provide additional management challenges.

 

Fit Out has seen no significant change to performance or order book in Q3 compared to the first half, however there are early indications of increasing confidence of market improvement through 2014 and beyond.

 

As expected, performance in Affordable Housing has improved in Q3 over the first half. This has been driven primarily by continued positive trends in its open market housing activities, with an increase in open market house sale completions of 41% in the nine months of 2013, compared to the same period in 2012. However, there remains significant competitive pressure on construction revenue and margins, exacerbated by increasing material costs and subcontractor costs.

 

The level of activity on Urban Regeneration projects continues to provide confidence that the division is well-placed to benefit from 2014 onwards. Since the half year, the division was appointed by South Tyneside Council as the sole developer of the £100m South Shields 365 town centre renewal.

 

Investments continued with its strategy of recycling its invested capital, with the sale of its interest in Tayside Health Holdings Limited during the period, at a value in line with expected returns from this division.

 

Financial Position

Net debt as at 31 October 2013 was £15m. The average daily net debt from the start of the year up to 31 October was £23m, a continued improvement from the half year average of £32m. Q3 average daily net debt was £13m.

Outlook

Based upon current progress across all its activities, the Group is on course to deliver a result for the year in line with the Board's expectations. Looking further ahead, the Board remains confident that the business is well-positioned to benefit from profitable opportunities as its markets recover.

 

ENDS

Morgan Sindall Group

Morgan Sindall Group plc is a leading UK construction and regeneration group with revenue of c£2 billion, employing around 6,500 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, fit out, affordable housing, urban regeneration and investments.

 

ENQUIRIES:

 

Morgan Sindall Group Tel: 020 7307 9200

John Morgan, Chief Executive

Steve Crummett, Finance Director

 

Brunswick Tel: 020 7404 5959

Jonathan Glass

Nina Coad

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDBCXGBGXL
Date   Source Headline
4th Jun 202611:43 amRNSDirector/PDMR Shareholding
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.